CytomX(CTMX)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CTMX CytomX

交易中 12-23 14:27:02 EST

1.09

+0.00

-0.46%

最高1.11	最低1.05	成交量87.90万
今开1.08	昨收1.09	日振幅5.05%
总市值8,491万	流通市值7,838万	总股本7,826万
成交额95.40万	换手率1.22%	流通股本7,224万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CTMX","market":"US","secType":"STK","nameCN":"CytomX","latestPrice":1.085,"timestamp":1734982003941,"preClose":1.09,"halted":0,"volume":878986,"delay":0,"floatShares":72235199,"shares":78258879,"eps":0.161506,"marketStatus":"交易中","marketStatusCode":2,"change":-0.005,"latestTime":"12-23 14:27:02 EST","open":1.0793,"high":1.105,"low":1.05,"amount":953966.4064538,"amplitude":0.050459,"askPrice":1.09,"askSize":200,"bidPrice":1.08,"bidSize":810,"shortable":3,"etf":0,"ttmEps":0.161506,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734987600000},"adr":0,"listingDate":1444276800000,"adjPreClose":1.09,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.1,"preClose":1.09,"latestTime":"09:27 EST","volume":11012,"amount":12038.8183448,"timestamp":1734964074224},"postHourTrading":{"tag":"盘后","latestPrice":1.067,"preClose":1.09,"latestTime":"18:50 EST","volume":112477,"amount":122517.9033,"timestamp":1734738653097},"volumeRatio":1.171316,"impliedVol":0.5717,"impliedVolPercentile":0.1952},"requestUrl":"/m/hq/s/CTMX/tweets","defaultTab":"tweets","newsList":[{"id":"2492498136","title":"Cytomx Therapeutics, Inc.盘中异动 临近午盘股价大跌5.31%报1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492498136","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492498136?lang=zh_cn&edition=full","pubTime":"2024-12-19 00:56","pubTimestamp":1734540982,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日00时56分，Cytomx Therapeutics, Inc.股票出现波动，股价急速下挫5.31%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。其相关个股中，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为2803.59%、573.15%、313.15%，振幅较大的相关个股有Polyrizon Ltd.、Cognition Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为227.62%、118.27%、98.06%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219005622a1f8ffa3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219005622a1f8ffa3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTMX","BK4139","LENZ"],"gpt_icon":0},{"id":"2492896972","title":"Cytomx Therapeutics, Inc.盘中异动 早盘股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492896972","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492896972?lang=zh_cn&edition=full","pubTime":"2024-12-17 23:17","pubTimestamp":1734448672,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日23时17分，Cytomx Therapeutics, Inc.股票出现波动，股价急速下跌5.22%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Portage Biotech Inc.、Tonix Pharmaceuticals Holding Corp.、Marker Therapeutics, Inc.涨幅较大，Portage Biotech Inc.、Tonix Pharmaceuticals Holding Corp.、Polyrizon Ltd.较为活跃，换手率分别为1728.52%、205.53%、101.08%，振幅较大的相关个股有Tonix Pharmaceuticals Holding Corp.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Portage Biotech Inc.，振幅分别为113.21%、95.10%、78.77%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121723175295ea333f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121723175295ea333f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTMX","BK4139","LENZ"],"gpt_icon":0},{"id":"2490874613","title":"Cytomx Therapeutics, Inc.盘中异动 大幅下跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490874613","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490874613?lang=zh_cn&edition=full","pubTime":"2024-12-12 22:57","pubTimestamp":1734015447,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日22时57分，Cytomx Therapeutics, Inc.股票出现波动，股价大幅下挫5.08%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，Palisade Bio, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Trevi Therapeutics, Inc.涨幅较大，Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为2946.04%、709.86%、64.61%，振幅较大的相关个股有Palisade Bio, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Aptevo Therapeutics Inc.，振幅分别为56.43%、55.45%、37.26%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212225727ab72b538&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212225727ab72b538&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CTMX"],"gpt_icon":0},{"id":"2490014973","title":"Cytomx Therapeutics, Inc.盘中异动 股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490014973","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490014973?lang=zh_cn&edition=full","pubTime":"2024-12-10 22:54","pubTimestamp":1733842494,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日22时54分，Cytomx Therapeutics, Inc.股票出现波动，股价急速下跌5.16%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.07%。其相关个股中，Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Uniqure N.V.涨幅较大，Psyence Biomedical Ltd.、Processa Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为1851.53%、426.87%、98.44%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Chimerix, Inc.、Jupiter Neurosciences, Inc.，振幅分别为131.78%、83.23%、33.56%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210225454a1e3a36f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210225454a1e3a36f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTMX","LENZ","BK4139"],"gpt_icon":0},{"id":"2489395372","title":"Cytomx Therapeutics, Inc.盘中异动 急速拉升5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489395372","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489395372?lang=zh_cn&edition=full","pubTime":"2024-12-06 22:38","pubTimestamp":1733495927,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日22时38分，Cytomx Therapeutics, Inc.股票出现异动，股价快速上涨5.17%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Cardio Diagnostics Holdings Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Molecular Templates, Inc.、Psyence Biomedical Ltd.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为28.08%、25.19%、13.89%，振幅较大的相关个股有Ensysce Biosciences, Inc.、Molecular Templates, Inc.、Cardio Diagnostics Holdings Inc.，振幅分别为13.20%、12.79%、12.70%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206223847971c2515&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206223847971c2515&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CTMX","LENZ"],"gpt_icon":0},{"id":"2488809190","title":"Cytomx Therapeutics, Inc.盘中异动 早盘大幅拉升7.36%报1.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488809190","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488809190?lang=zh_cn&edition=full","pubTime":"2024-12-04 23:04","pubTimestamp":1733324649,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日23时04分，Cytomx Therapeutics, Inc.股票出现波动，股价快速拉升7.36%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Cyclerion Therapeutics, Inc.、Exicure, Inc.、Heron Therapeutics, Inc.涨幅较大，Cyclerion Therapeutics, Inc.、Can Fite Biopharma Ltd、Windtree Therapeutics, Inc.较为活跃，换手率分别为2377.92%、217.96%、121.29%，振幅较大的相关个股有Cyclerion Therapeutics, Inc.、Eterna Therapeutics Inc.、Heron Therapeutics, Inc.，振幅分别为237.89%、54.25%、34.75%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204230410a26c6f84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204230410a26c6f84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTMX","LENZ","BK4139"],"gpt_icon":0},{"id":"2488945775","title":"Cytomx Therapeutics, Inc.盘中异动 快速拉升11.93%报1.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488945775","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488945775?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:31","pubTimestamp":1733236308,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时31分，Cytomx Therapeutics, Inc.股票出现波动，股价急速拉升11.93%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。其相关个股中，Janux Therapeutics, Inc.、Coherus Biosciences, Inc.、Vir Biotechnology, Inc.涨幅较大，Nls Pharmaceutics Ltd.、Purple Biotech Ltd、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为129.37%、56.65%、52.10%，振幅较大的相关个股有Coherus Biosciences, Inc.、Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为15.33%、12.00%、11.65%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223150a2699560&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223150a2699560&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTMX","LENZ","BK4139"],"gpt_icon":0},{"id":"2487516569","title":"Cytomx Therapeutics, Inc.盘中异动 早盘大幅上涨5.88%报1.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2487516569","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487516569?lang=zh_cn&edition=full","pubTime":"2024-11-29 23:58","pubTimestamp":1732895926,"startTime":"0","endTime":"0","summary":"北京时间2024年11月29日23时58分，Cytomx Therapeutics, Inc.股票出现波动，股价快速拉升5.88%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Passage Bio, Inc.、Cabaletta Bio, Inc.涨幅较大，Silo Pharma, Inc.、Klotho Neurosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为174.26%、61.82%、61.61%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为130.29%、105.44%、68.75%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129235846abe91198&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129235846abe91198&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CTMX","LENZ"],"gpt_icon":0},{"id":"2486604838","title":"Cytomx Therapeutics, Inc.盘中异动 股价大涨6.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486604838","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486604838?lang=zh_cn&edition=full","pubTime":"2024-11-27 03:16","pubTimestamp":1732648588,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日03时16分，Cytomx Therapeutics, Inc.股票出现异动，股价急速上涨6.22%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Poseida Therapeutics, Inc.、Surrozen Inc C/Wts 01/08/2031 、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，木薯科学、Elevai Labs, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为52.80%、51.50%、33.03%，振幅较大的相关个股有Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Tc Biopharm  Plc C/Wts 10/02/2028 、Lakeshore Biopharma Co., Ltd，振幅分别为85.82%、57.50%、55.39%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127031629a257bddd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127031629a257bddd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTMX","LENZ","BK4139"],"gpt_icon":0},{"id":"2486034343","title":"Cytomx Therapeutics, Inc.盘中异动 股价大涨5.25%报0.937美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486034343","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486034343?lang=zh_cn&edition=full","pubTime":"2024-11-26 00:06","pubTimestamp":1732550762,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日00时06分，Cytomx Therapeutics, Inc.股票出现波动，股价急速拉升5.25%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.80%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Alpha Tau Medical Ltd C/Wts 涨幅较大，木薯科学、Cognition Therapeutics, Inc.、Exicure, Inc.较为活跃，换手率分别为115.82%、102.18%、72.08%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Exicure, Inc.，振幅分别为94.06%、78.65%、75.84%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112600060298e44748&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112600060298e44748&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTMX","BK4139","LENZ"],"gpt_icon":0},{"id":"2484920176","title":"Cytomx Therapeutics, Inc.盘中异动 股价大涨6.26%报0.917美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484920176","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484920176?lang=zh_cn&edition=full","pubTime":"2024-11-20 00:59","pubTimestamp":1732035579,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日00时59分，Cytomx Therapeutics, Inc.股票出现波动，股价急速拉升6.26%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.79%。其相关个股中，Syros Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Exicure, Inc.涨幅较大，Tff Pharmaceuticals, Inc.、Syros Pharmaceuticals, Inc.、Exicure, Inc.较为活跃，换手率分别为819.73%、578.64%、128.05%，振幅较大的相关个股有Syros Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为91.10%、81.67%、62.18%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120005940abcfaa9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120005940abcfaa9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTMX","BK4139","LENZ"],"gpt_icon":0},{"id":"2484674567","title":"Cytomx Therapeutics, Inc.盘中异动 股价大跌5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484674567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484674567?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:04","pubTimestamp":1731942265,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时04分，Cytomx Therapeutics, Inc.股票出现波动，股价大幅下挫5.57%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.53%。其相关个股中，Hcw Biologics Inc.、Apollomics Inc C/Wts 01/04/2028 、冠科美博涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为553.10%、458.67%、322.30%，振幅较大的相关个股有Hcw Biologics Inc.、冠科美博、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为118.81%、72.26%、71.83%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118230425971a733d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118230425971a733d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTMX","LENZ","BK4139"],"gpt_icon":0},{"id":"2484543619","title":"Cytomx Therapeutics, Inc.2024财年第三财季实现净利润5.74百万美元，同比增加91.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484543619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484543619?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:04","pubTimestamp":1731773097,"startTime":"0","endTime":"0","summary":"11月17日，Cytomx Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为5.74百万美元，同比增加91.97%；其中营业收入为33.43百万美元，同比增加26.72%，每股基本收益为0.07美元。从资产负债表来看，Cytomx Therapeutics, Inc.总负债1.62亿美元，其中短期债务5.00百万美元，资产负债比为0.86，流动比率为1.05。机构评级：截至2024年11月17日，当前有5家机构对Cytomx Therapeutics, Inc.目标价做出预测，其中目标均价为5.29美元，其中最低目标价为3.25美元，最高目标价为8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000636abc79248&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000636abc79248&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CTMX"],"gpt_icon":0},{"id":"2481101911","title":"Cytomx Therapeutics, Inc.盘中异动 股价大涨15.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481101911","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481101911?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:34","pubTimestamp":1731076445,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时34分，Cytomx Therapeutics, Inc.股票出现波动，股价急速上涨15.00%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Fortrea Holdings Inc.、Poseida Therapeutics, Inc.涨幅较大，Elevai Labs, Inc.、Matinas Biopharma Holdings, Inc.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为395.92%、16.85%、14.88%，振幅较大的相关个股有Cardiff Oncology, Inc.、Rigel Pharmaceuticals, Inc.、Anebulo Pharmaceuticals, Inc.，振幅分别为18.09%、16.52%、14.96%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822340695bdef72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822340695bdef72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTMX","BK4139","LENZ"],"gpt_icon":0},{"id":"2481617400","title":"CytomX Therapeutics Inc    预计每股亏损 17 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481617400","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481617400?lang=zh_cn&edition=full","pubTime":"2024-11-06 13:23","pubTimestamp":1730870622,"startTime":"0","endTime":"0","summary":"   * CytomX Therapeutics Inc    将于11月7日公布截至2024年9月30日的财报，预计该公司的季度收入将出现下降。* 根据LSEG的数据，7位分析师的平均预期显示，这家总部位于加利福尼亚州旧金山南部的公司的营收将从去年同期的2638万美元下降33.6%，至1751.4万美元。* LSEG 分析师对 CytomX Therapeutics Inc 的平均预期是每股亏损 17 美分。* 华尔街对 CytomX Therapeutics Inc 的 12 个月目标价中位数为 3.56 美元，高于上一次 0.99 美元的收盘价。11月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTMX","LENZ"],"gpt_icon":0},{"id":"2481445537","title":"Cytomx Therapeutics, Inc.盘中异动 快速下跌5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481445537","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481445537?lang=zh_cn&edition=full","pubTime":"2024-11-05 02:06","pubTimestamp":1730743594,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日02时06分，Cytomx Therapeutics, Inc.股票出现波动，股价急速下挫5.48%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Neurogene Inc.、Tenaya Therapeutics, Inc.、Disc Medicine, Inc.涨幅较大，Elevai Labs, Inc.、Nls Pharmaceutics Ltd.、Tc Biopharm  Plc较为活跃，换手率分别为403.85%、282.01%、83.73%，振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、In8Bio, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为52.25%、45.39%、43.11%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105020634971a43a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105020634971a43a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTMX","LENZ","BK4139"],"gpt_icon":0},{"id":"2480890743","title":"CytomX Therapeutics Inc    预计每股亏损 17 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2480890743","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480890743?lang=zh_cn&edition=full","pubTime":"2024-11-02 11:52","pubTimestamp":1730519568,"startTime":"0","endTime":"0","summary":"   * CytomX Therapeutics Inc    将于11月7日公布截至2024年9月30日的财报，预计该公司的季度收入将出现下降。* 根据LSEG的数据，7位分析师的平均预期显示，这家总部位于加利福尼亚州旧金山南部的公司的营收将从去年同期的2638万美元下降33.6%，至1751.4万美元。* LSEG 分析师对 CytomX Therapeutics Inc 的平均预期是每股亏损 17 美分。* 华尔街对 CytomX Therapeutics Inc 的 12 个月目标价中位数为 3.56 美元，高于其上次收盘价 1.05 美元。11月2日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTMX","LENZ"],"gpt_icon":0},{"id":"2478796647","title":"Cytomx Therapeutics, Inc.盘中异动 临近收盘股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478796647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478796647?lang=zh_cn&edition=full","pubTime":"2024-10-26 03:59","pubTimestamp":1729886388,"startTime":"0","endTime":"0","summary":"北京时间2024年10月26日03时59分，Cytomx Therapeutics, Inc.股票出现波动，股价大幅跳水5.09%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Iterum Therapeutics Plc、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，180 Life Sciences Corp.、Elevai Labs, Inc.、Iterum Therapeutics Plc较为活跃，换手率分别为878.28%、800.23%、452.19%，振幅较大的相关个股有Iterum Therapeutics Plc、Elevai Labs, Inc.、Qualigen Therapeutics, Inc.，振幅分别为102.56%、93.82%、91.58%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026035948a1eb36d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026035948a1eb36d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CTMX"],"gpt_icon":0},{"id":"2477353822","title":"Cytomx Therapeutics, Inc.盘中异动 股价大跌5.17%报1.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477353822","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477353822?lang=zh_cn&edition=full","pubTime":"2024-10-22 22:04","pubTimestamp":1729605841,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日22时04分，Cytomx Therapeutics, Inc.股票出现波动，股价大幅下跌5.17%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.86%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Aptevo Therapeutics Inc.涨幅较大，Genprex, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3643.58%、2348.83%、1766.86%，振幅较大的相关个股有Ensysce Biosciences, Inc.、Aptevo Therapeutics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为140.78%、99.41%、67.84%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102222040198e3dc89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102222040198e3dc89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTMX","LENZ","BK4139"],"gpt_icon":0},{"id":"2476978929","title":"Cytomx Therapeutics, Inc.盘中异动 急速拉升5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476978929","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476978929?lang=zh_cn&edition=full","pubTime":"2024-10-17 03:56","pubTimestamp":1729108574,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日03时56分，Cytomx Therapeutics, Inc.股票出现异动，股价快速拉升5.36%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.60%。其相关个股中，180 Life Sciences Corp.、Proqr Therapeutics N.V.、Korro Bio, Inc.涨幅较大，180 Life Sciences Corp.、Quoin Pharmaceuticals Ltd、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为8562.71%、2097.26%、1231.17%，振幅较大的相关个股有180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025、Quoin Pharmaceuticals Ltd，振幅分别为745.07%、279.52%、198.41%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101703561498e3cd89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101703561498e3cd89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTMX","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cytomx.com","stockEarnings":[{"period":"1week","weight":-0.018},{"period":"1month","weight":0.2527},{"period":"3month","weight":-0.084},{"period":"6month","weight":-0.155},{"period":"1year","weight":-0.227},{"period":"ytd","weight":-0.2968}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CytomX Therapeutics, Inc.于2010年9月在特拉华州注册成立。该公司是一家临床阶段、专注于肿瘤学的生物制药公司，专注于开发旨在定位于肿瘤微环境的新型条件激活生物制剂。该公司专有、多功能、多模态的PROBODY技术平台旨在使肿瘤微环境内的生物治疗候选药物能够有条件地激活，同时最大限度地减少健康组织和循环中的药物活性。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.098508},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.007093},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.031361},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.028412},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.068706},{"month":6,"riseRate":0.444444,"avgChangeRate":-0.024186},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.05037},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.010417},{"month":9,"riseRate":0.222222,"avgChangeRate":-0.024094},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.090956},{"month":11,"riseRate":0.8,"avgChangeRate":0.176661},{"month":12,"riseRate":0.6,"avgChangeRate":0.010346}],"exchange":"NASDAQ","name":"CytomX","nameEN":"CytomX Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CytomX(CTMX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CytomX(CTMX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CytomX,CTMX,CytomX股票,CytomX股票老虎,CytomX股票老虎国际,CytomX行情,CytomX股票行情,CytomX股价,CytomX股市,CytomX股票价格,CytomX股票交易,CytomX股票购买,CytomX股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CytomX(CTMX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CytomX(CTMX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况